决定对原发性逆皮质肉瘤进行个人治疗
Deanna Ng1, Alexander Bertrand1, Roberta Sanfilippo2
1Department of Surgery, University of Toronto, Toronto, ON, Canada.
Expert review of anticancer therapy
|October 4, 2023
概括
逆皮质肉瘤 (RPS) 是一种罕见的瘤,需要量身定制的治疗. 以组织学为导向的方法,考虑个体患者的因素,改善了这些具有挑战性的介质细胞恶性瘤的结果.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 医学瘤学 医学瘤学
背景情况:
- 逆皮质肉瘤 (RPS) 是一种罕见的介质细胞瘤,占所有恶性瘤的0.1-0.2%.
- 管理是复杂的,手术切除是主要治疗方法.
- 国际合作改善了理解和个性化护理,导致更好的生存率.
研究的目的:
- 审查有关初级RPS管理的当前文献.
- 强调以组织学为导向的方法来实现个性化治疗策略.
- 总结最近在RPS管理方面的进展和未来方向.
主要方法:
- 对1993年至2023年间发表的文章进行了全面的文献搜索.
- 专注于研究研究RPS的预后因素和治疗方法的研究.
- 综合发现,突出最近的进展和未来的研究方向.
主要成果:
- 由于组织学异质性和对治疗的不同反应,RPS管理需要个性化的方法.
- 组织学和等级影响复发模式和对新辅助治疗的敏感性.
- 个性化治疗途径对于优化患者的治疗结果至关重要.
结论:
- 以组织学为导向的方法对于管理初级RPS至关重要.
- 了解预后因素和根据患者个体特征量身定制治疗是关键.
- 对新辅助疗法的进一步研究,包括放射治疗和化疗,将完善个性化治疗策略.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


